Stoke Therapeutics Inc (NASDAQ:STOK)
| 14.58 BATS BZX Real-Time Price As of 10:13am ET |  +0.43 / +3.04%Today’s Change | 9.55 Today|||52-Week Range 34.83 | -39.22% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 1 2018 | Quarter 1 2019 | -- | -- | |||
| Operating Activities | Net Income / Starting Line | -1.9M | -5.7M | -- | -- | |
| Depreciation | 32.0K | 80.0K | -- | -- | ||
| Total Other Cash Flow | 4.0K | 184.0K | -- | -- | ||
| Funds From Operations | -1.9M | -5.5M | -- | -- | ||
| Funds From/For Other Operating Expenses | 113.0K | 1.1M | -- | -- | ||
| Net Cash Flow - Operating Activities | -2.0M | -6.5M | -- | -- | ||
| Investing | Capital Expenditures | -26.0K | -92.0K | -- | -- | |
| Fixed Asset Disposal | 0.00 | 2.0K | -- | -- | ||
| Net Cash Flow Investing | -26.0K | -90.0K | -- | -- | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | -- | -- | -- |
| Long Term Borrowings | 0.00 | 0.00 | -- | -- | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | -- | -- | -- | |
| Net Proceeds Stock Sale | 12.4M | -67.0K | -- | -- | ||
| Common Preferred Redeemed | 0.00 | 0.00 | -- | -- | -- | |
| Common Dividends | -- | -- | -- | -- | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | -- | -- | -- | |
| Other Sources - Financing | 0.00 | 0.00 | -- | -- | -- | |
| Other Uses - Financing | 1.0K | 1.0K | -- | -- | ||
| Net Cash Flow - Financing | 12.4M | -68.0K | -- | -- | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 10.4M | -6.7M | -- | -- | ||
